Cargando…
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic cells (DC). mCD83 regulates maturation, activ...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568190/ https://www.ncbi.nlm.nih.gov/pubmed/31231400 http://dx.doi.org/10.3389/fimmu.2019.01312 |
_version_ | 1783427214261354496 |
---|---|
author | Li, Ziduo Ju, Xinsheng Silveira, Pablo A. Abadir, Edward Hsu, Wei-Hsun Hart, Derek N. J. Clark, Georgina J. |
author_facet | Li, Ziduo Ju, Xinsheng Silveira, Pablo A. Abadir, Edward Hsu, Wei-Hsun Hart, Derek N. J. Clark, Georgina J. |
author_sort | Li, Ziduo |
collection | PubMed |
description | CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic cells (DC). mCD83 regulates maturation, activation and homeostasis. Soluble CD83 (sCD83), which is elevated in the serum of patients with autoimmune disease and some hematological malignancies is reported to have an immune suppressive function. While CD83 is emerging as a promising immune modulator with therapeutic potential, some important aspects such as its ligand/s, intracellular signaling pathways and modulators of its expression are unclear. In this review we discuss the recent biological findings and the potential clinical value of CD83 based therapeutics in various conditions including autoimmune disease, graft-vs.-host disease, transplantation and hematological malignancies. |
format | Online Article Text |
id | pubmed-6568190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65681902019-06-21 CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential Li, Ziduo Ju, Xinsheng Silveira, Pablo A. Abadir, Edward Hsu, Wei-Hsun Hart, Derek N. J. Clark, Georgina J. Front Immunol Immunology CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic cells (DC). mCD83 regulates maturation, activation and homeostasis. Soluble CD83 (sCD83), which is elevated in the serum of patients with autoimmune disease and some hematological malignancies is reported to have an immune suppressive function. While CD83 is emerging as a promising immune modulator with therapeutic potential, some important aspects such as its ligand/s, intracellular signaling pathways and modulators of its expression are unclear. In this review we discuss the recent biological findings and the potential clinical value of CD83 based therapeutics in various conditions including autoimmune disease, graft-vs.-host disease, transplantation and hematological malignancies. Frontiers Media S.A. 2019-06-07 /pmc/articles/PMC6568190/ /pubmed/31231400 http://dx.doi.org/10.3389/fimmu.2019.01312 Text en Copyright © 2019 Li, Ju, Silveira, Abadir, Hsu, Hart and Clark. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Li, Ziduo Ju, Xinsheng Silveira, Pablo A. Abadir, Edward Hsu, Wei-Hsun Hart, Derek N. J. Clark, Georgina J. CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential |
title | CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential |
title_full | CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential |
title_fullStr | CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential |
title_full_unstemmed | CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential |
title_short | CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential |
title_sort | cd83: activation marker for antigen presenting cells and its therapeutic potential |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568190/ https://www.ncbi.nlm.nih.gov/pubmed/31231400 http://dx.doi.org/10.3389/fimmu.2019.01312 |
work_keys_str_mv | AT liziduo cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential AT juxinsheng cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential AT silveirapabloa cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential AT abadiredward cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential AT hsuweihsun cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential AT hartdereknj cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential AT clarkgeorginaj cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential |